Navigation Links
Marshall Edwards Announces Private Placement
Date:5/2/2011

SAN DIEGO, May 2, 2011 /PRNewswire/ -- Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today that it has entered into a definitive agreement with certain institutional investors to sell in a private placement common stock and warrants for gross proceeds of up to $4 million, before deducting fees and expenses of the offering, of which approximately $1.1 million would result from the sale of approximately 835,217 shares of common stock at $1.333 per share. The remaining $2.9 million would be subject to the exercise of one-year series B warrants at their initial exercise price of $1.333 per share and the fulfillment or waiver of certain conditions.

The Company will also issue series A warrants which will initially represent the right to purchase up to 626,413 shares of common stock exercisable after six months for a period of five years and subject to proportionate increases to the extent the series B warrants are exercised. Series C warrants may entitle the holders to obtain additional shares of common stock exercisable in the event the trading price of the common stock is below certain levels on specified future dates during a period of up to one year following the closing date.

The offering is expected to close on or about May 13, 2011, subject to certain customary closing conditions as well as the closing of the transactions contemplated by the asset purchase agreement entered into between the Company and its majority shareholder, Novogen Limited, and Novogen Research Pty Limited on December 21, 2010, which is pending approval at a meeting of Novogen shareholders on May 6, 2011.

The net proceeds from the offering will be used primarily to continue development of Marshall Edwards' two lead oncology programs, including a Phase I clinical trial of its intr
'/>"/>

SOURCE Marshall Edwards, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Marshall Edwards Announces Publication of Phase II Clinical Trial Results Highlighting Activity of Intravenous Phenoxodiol
2. Marshall Edwards Receives Positive Response From NASDAQ
3. Marshall Edwards to Host Annual Meeting of Stockholders
4. Marshall Edwards Receives NASDAQ Notice Of Non-Compliance; Intends To Request Hearing
5. Marshall Edwards Announces Presentation of New Data Showing Activity in Chemotherapy-Resistant Ovarian Cancer Cells
6. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
7. Edwards Resilient Trial Demonstrates Statistically Superior Results for Treating Peripheral Arterial Disease in the Leg
8. Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film
9. Esperion Announces Results From Phase 1 Study and Four Preclinical Studies for ETC-1002
10. Regeneron Announces Presentation at the Bank of America Merrill Lynch 2011 Health Care Conference
11. Amira Pharmaceuticals Announces Completion of Phase 1 Clinical Study for AM152, A Novel LPA1 Receptor Antagonist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... SAN ANTONIO , Jan. 15, 2014 Most ... take, according to a recent online survey* sponsored by ... among the National Osteoporosis Foundation online support community, ... to take medication that comes in a form other ...
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: CLSN ) ... investors to purchase an aggregate of approximately $15 million ... direct offering, led by a dedicated health care fund. ... with these investors pursuant to which the Company agreed ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and ... be able to protect their most important business ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of the ... steadfastly remains one of the most litigious industry ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2
... Fla., April 20, 2011 Legal-Bay LLC, through its ... making a substantial commitment to plaintiffs in need of ... Cases.  Legal-Bay is already an industry leader; however they ... funding areas.  Recently the company announced that they have ...
... 2011 The Society of ... taking a leading role in measuring and assessing radiation ... and reduction of skin dosage; and promoting the safety ... this month in the Journal of Vascular and Interventional ...
Cached Medicine Technology:Legal-Bay LLC Announces Opening of Jones Act Lawsuit Funding Division 2Society of Interventional Radiology Addresses Radiation Safety, Advances Best Practices 2Society of Interventional Radiology Addresses Radiation Safety, Advances Best Practices 3Society of Interventional Radiology Addresses Radiation Safety, Advances Best Practices 4Society of Interventional Radiology Addresses Radiation Safety, Advances Best Practices 5
(Date:7/11/2014)... adults who screened positive for a history of hazardous ... than 50 percent after receiving mobile phone text messages ... a study published online yesterday in Annals of ... for Young Adult Emergency Department Patients: A Randomized Clinical ... than 50,000 adults ages 18 to 24 visit ERs ...
(Date:7/11/2014)... Recently, Fadhits.com, the distinguished wedding dress manufacturer and retailer, has ... To bring more benefits to worldwide clients in this great ... for these brand new items. Clients can enjoy thwe special ... says gladly, “We are happy to announce such a promotion. ... new and old customers and strengthen our relationship with them. ...
(Date:7/11/2014)... Hills, CA (PRWEB) July 11, 2014 Bedros ... marketing expert; a title he’s earned by founding the fast-selling ... professionals on marketing their businesses. He works with successful boot ... blog post on the traits of the most successful ... earners share three important qualities. , “I’ve worked with and ...
(Date:7/11/2014)... H.E.A.R Me Out Listens to Needs of Hearing ... provide comprehensive information and services available to Colorado’s hearing ... with hearing loss, this organization is the first of ... local and state resources that aims to give new ... Me Out and its website was founded by Colorado ...
(Date:7/11/2014)... is history in much of the world, but remains ... vaccinated children an extra dose of inactivated polio vaccine ... infectious disease, a new study suggests. Although the ... as a year after vaccination. Vaccinated children and adults ... of the disease, according to background information in the ...
Breaking Medicine News(10 mins):Health News:Text message medicine: Texts from the ER can reduce binge drinking 2Health News:Promotion for Kids Prom Dresses Now Provided at Fadhits.com 2Health News:Fitness Boot Camp Marketing Expert Bedros Keuilian Shares the Top Three Traits of Successful Boot Camp Owners 2Health News:Fitness Boot Camp Marketing Expert Bedros Keuilian Shares the Top Three Traits of Successful Boot Camp Owners 3Health News:H.E.A.R Me Out Listens to Needs of Hearing Impaired 2Health News:H.E.A.R Me Out Listens to Needs of Hearing Impaired 3Health News:Researchers Assess New Way to Boost Polio Immunity 2
... study has found that among women who have never ... increased risk of developing ovarian cancer compared with women ... issue of CANCER , a peer-reviewed journal of ... may contribute to the development of ovarian cancer through ...
... is urging women to continue waging a battle against the Food ... hormones. , ... Potomac, MD (PRWEB) January 2, 2009 ... health practitioner, is urging women to continue waging a battle against ...
... The National Parkinson Foundation (NPF) awarded ... new evidence-based interventions aimed at preventing falls in ... grants to five different research projects at NPF ... and the United States. NPF supports a ...
... asks you to help save lives by donating blood ... being held on Tuesday, January 6th from 2 pm ... Gloucester City, New Jersey. To make an immediate ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20081216/DC52619LOGO ) Goldglantz suffered 3rd ...
... while performing winter task , , FRIDAY, Jan. 2 (HealthDay ... can be physically challenging and dangerous work, so you ... the American Academy of Orthopaedic Surgeons (AAOS). , ... U.S. hospital emergency rooms, doctors, offices, clinics and other ...
... key to understanding, and perhaps killing, dormant ovarian cancer ... years later, researchers at The University of Texas M. ... Journal of Clinical Investigation . , The team found ... a switch for autophagy, or self-cannibalization, in ovarian cancer ...
Cached Medicine News:Health News:Study links obesity to elevated risk of ovarian cancer 2Health News:Susan Lark, MD Urges Women to Fight for Their Right to Use Bioidentical Hormones 2Health News:Susan Lark, MD Urges Women to Fight for Their Right to Use Bioidentical Hormones 3Health News:The National Parkinson Foundation Awards Five Grants for the Falls Prevention Initiative 2Health News:The National Parkinson Foundation Awards Five Grants for the Falls Prevention Initiative 3Health News:Blood Drive Held in Honor of Gloucester City Resident - Evan Goldglantz 2Health News:Shovel Snow Safely 2Health News:Dormant cancer cells rely on cellular self-cannibalization to survive 2
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride....
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride....
Inoculum Broth with Calcium Chloride and Phytone....
...
Medicine Products: